First Bank & Trust Bridge Bio Pharma, Inc. Transaction History
First Bank & Trust
- $546 Million
- Q2 2025
A detailed history of First Bank & Trust transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, First Bank & Trust holds 8,822 shares of BBIO stock, worth $405,635. This represents 0.07% of its overall portfolio holdings.
Number of Shares
8,822
Previous 8,493
3.87%
Holding current value
$405,635
Previous $293,000
29.69%
% of portfolio
0.07%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
184MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$1.01 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$886 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$685 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$572 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$330 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.82B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...